Assyro AI

FDA Orange Book · active-ingredient family

Chloroprocaine hydrochloride

Chloroprocaine hydrochloride is approved as 3 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:IHEEZO · NDA 216227

3

Brand (NDA)

3

Generics (ANDA)

4

Listed patents

0

Exclusivity periods

Brand (NDA) products · gel, injectable, solution

ProductApplicantApplicationTEApproved
IHEEZORLDHARROW EYENDA 216227Sep 27, 2022
CLOROTEKALRLDB BRAUN MEDICALNDA 208791Sep 26, 2017
NESACAINERLD×6FRESENIUS KABI USANDA 009435Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
CHLOROPROCAINE HYDROCHLORIDE×2HIKMAANDA 040273APSep 09, 1998
CHLOROPROCAINE HYDROCHLORIDEHOSPIRAANDA 087447Apr 16, 1982
CHLOROPROCAINE HYDROCHLORIDEHOSPIRAANDA 087446Apr 16, 1982

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8969412Sep 05, 2026in 3 mo
ProductU-2609
9504666Dec 11, 2033in 7 yr 7 mo
Product
10792271Sep 15, 2038in 12 yr 5 mo
ProductU-3457
11969403May 14, 2039in 13 yr 1 mo
Product

Chloroprocaine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.